Drawing for KETOSENS

USPTO serial 88385084

KETOSENS

Reviewed by CopyMark Law Group

Reg. 6032138Status 702Registered
Filing date
Status date
Registration date
Apr 14, 2020
Examiner
SNAPP, TINA LOUISE
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with KETOSENS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Young Seok Koo

Young Seok Koo Womble Bond Dickinson (US) LLP400 Spectrum Center DriveSuite 1700Irvine, CA 92618

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic agents for medical use; enzyme preparations for medical purposes; diagnostic reagents for immunization for medicinal use; reagents for medical use; diagnostic test reagents for medical purposes; medical diagnostic reagents for testing and analyzing body fluids; in vitro diagnostic reagents for medical purposes; [cotton for medical purposes;] medical diagnostic test strips for blood analysis; test strips for testing blood glucose levels; diagnostic reagents for measuring blood ketone levels for medicinal use; control solutions in the nature of chemical reagents for blood ketone monitoring devices for medical purposesACTIVEMar 16, 2019
010Blood testing apparatus; analyzers for medical diagnosis in the nature of medical diagnostic apparatus for analyzing and measuring electrolytes in the body; medical diagnostic apparatus and instruments for testing blood sugar levels; in vitro diagnostic devices in the nature of blood collecting devices for medical purposes; blood analysis equipment; blood analysis apparatus for medical diagnostic purposes; continuous blood glucose monitor in the nature of devices for monitoring blood glucose for medical purposes; apparatus for blood glucose monitoring for medical use; medical apparatus and instruments for use in medical diagnostic procedures; blood gas monitoring systems comprised of arterial blood gas measuring apparatus; blood coagulation measuring instruments in the nature of medical instruments for monitoring blood coagulation; [electrodes for medical use;] blood collecting devices being medical specimen collection devices in the nature of strips; apparatus for taking bloodACTIVEMar 16, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 1, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 1, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 17, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 28, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 9, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Apr 14, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 14, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 26, 2019ALIEASSIGNED TO LIE—
Dec 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 23, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2019DOCKASSIGNED TO EXAMINER—
May 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 17, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance